Histamine Intolerance Originates in the Gut.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary clinical trial data.
PubMed 33921522 · doi:10.3390/nu13041262
What was done
This narrative review summarizes existing literature on the pathophysiology, diagnosis, and management of histamine intolerance, focusing on gastrointestinal diamine oxidase (DAO) deficiency, mucosal involvement, and targeted dietary or enzyme interventions.
What was found
The abstract reports no quantitative data, statistics, or effect sizes. It qualitatively describes that deficient intestinal DAO activity impairs histamine degradation, generating functional gastrointestinal and extra-intestinal symptoms; that serum DAO values lack established correlation with gut mucosal DAO activity; and that histamine-reduced diets or oral DAO capsules can help alleviate symptoms.
Why it matters
It emphasizes histamine intolerance as a potential gastrointestinal contributor to unexplained functional symptoms that should be considered during clinical differential diagnosis.
Limits
The paper is a non-systematic narrative review providing no primary clinical data or pooled quantitative analyses. Diagnostic criteria rely heavily on nonspecific clinical questionnaires because serum DAO levels do not reliably mirror gut mucosal enzyme activity.
Cited by
- supports Diamine oxidase (DAO) is an enzyme taken orally to digest or break down dietary histamines.